Copyright Reports & Markets. All rights reserved.

Global Labeled Peptides Market Research Report 2021

Request for Sample of this report
Buy now

1 Labeled Peptides Market Overview

  • 1.1 Product Overview and Scope of Labeled Peptides
  • 1.2 Labeled Peptides Segment by Type
    • 1.2.1 Global Labeled Peptides Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 (Arg)9, FAM-labeled
    • 1.2.3 (Arg)9, TAMRA-labeled
    • 1.2.4 Others
  • 1.3 Labeled Peptides Segment by Application
    • 1.3.1 Global Labeled Peptides Sales Comparison by Application: (2021-2027)
    • 1.3.2 Protein Chemistry
    • 1.3.3 Immunology
    • 1.3.4 Histochemistry
    • 1.3.5 Others
  • 1.4 Global Labeled Peptides Market Size Estimates and Forecasts
    • 1.4.1 Global Labeled Peptides Revenue 2016-2027
    • 1.4.2 Global Labeled Peptides Sales 2016-2027
    • 1.4.3 Labeled Peptides Market Size by Region: 2016 Versus 2021 Versus 2027

2 Labeled Peptides Market Competition by Manufacturers

  • 2.1 Global Labeled Peptides Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Labeled Peptides Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Labeled Peptides Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Labeled Peptides Manufacturing Sites, Area Served, Product Type
  • 2.5 Labeled Peptides Market Competitive Situation and Trends
    • 2.5.1 Labeled Peptides Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Labeled Peptides Players Market Share by Revenue
    • 2.5.3 Global Labeled Peptides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Labeled Peptides Retrospective Market Scenario by Region

  • 3.1 Global Labeled Peptides Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Labeled Peptides Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Labeled Peptides Market Facts & Figures by Country
    • 3.3.1 North America Labeled Peptides Sales by Country
    • 3.3.2 North America Labeled Peptides Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Labeled Peptides Market Facts & Figures by Country
    • 3.4.1 Europe Labeled Peptides Sales by Country
    • 3.4.2 Europe Labeled Peptides Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Labeled Peptides Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Labeled Peptides Sales by Region
    • 3.5.2 Asia Pacific Labeled Peptides Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Labeled Peptides Market Facts & Figures by Country
    • 3.6.1 Latin America Labeled Peptides Sales by Country
    • 3.6.2 Latin America Labeled Peptides Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Labeled Peptides Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Labeled Peptides Sales by Country
    • 3.7.2 Middle East and Africa Labeled Peptides Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Labeled Peptides Historic Market Analysis by Type

  • 4.1 Global Labeled Peptides Sales Market Share by Type (2016-2021)
  • 4.2 Global Labeled Peptides Revenue Market Share by Type (2016-2021)
  • 4.3 Global Labeled Peptides Price by Type (2016-2021)

5 Global Labeled Peptides Historic Market Analysis by Application

  • 5.1 Global Labeled Peptides Sales Market Share by Application (2016-2021)
  • 5.2 Global Labeled Peptides Revenue Market Share by Application (2016-2021)
  • 5.3 Global Labeled Peptides Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Pepscan
    • 6.1.1 Pepscan Corporation Information
    • 6.1.2 Pepscan Description and Business Overview
    • 6.1.3 Pepscan Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Pepscan Labeled Peptides Product Portfolio
    • 6.1.5 Pepscan Recent Developments/Updates
  • 6.2 JPT Peptide Technologies
    • 6.2.1 JPT Peptide Technologies Corporation Information
    • 6.2.2 JPT Peptide Technologies Description and Business Overview
    • 6.2.3 JPT Peptide Technologies Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 JPT Peptide Technologies Labeled Peptides Product Portfolio
    • 6.2.5 JPT Peptide Technologies Recent Developments/Updates
  • 6.3 PEPTIDE INSTITUTE
    • 6.3.1 PEPTIDE INSTITUTE Corporation Information
    • 6.3.2 PEPTIDE INSTITUTE Description and Business Overview
    • 6.3.3 PEPTIDE INSTITUTE Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 PEPTIDE INSTITUTE Labeled Peptides Product Portfolio
    • 6.3.5 PEPTIDE INSTITUTE Recent Developments/Updates
  • 6.4 Merck
    • 6.4.1 Merck Corporation Information
    • 6.4.2 Merck Description and Business Overview
    • 6.4.3 Merck Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merck Labeled Peptides Product Portfolio
    • 6.4.5 Merck Recent Developments/Updates
  • 6.5 BIOSYNTAN GmbH
    • 6.5.1 BIOSYNTAN GmbH Corporation Information
    • 6.5.2 BIOSYNTAN GmbH Description and Business Overview
    • 6.5.3 BIOSYNTAN GmbH Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 BIOSYNTAN GmbH Labeled Peptides Product Portfolio
    • 6.5.5 BIOSYNTAN GmbH Recent Developments/Updates
  • 6.6 LifeTein
    • 6.6.1 LifeTein Corporation Information
    • 6.6.2 LifeTein Description and Business Overview
    • 6.6.3 LifeTein Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 LifeTein Labeled Peptides Product Portfolio
    • 6.6.5 LifeTein Recent Developments/Updates
  • 6.7 Eurogentec
    • 6.6.1 Eurogentec Corporation Information
    • 6.6.2 Eurogentec Description and Business Overview
    • 6.6.3 Eurogentec Labeled Peptides Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Eurogentec Labeled Peptides Product Portfolio
    • 6.7.5 Eurogentec Recent Developments/Updates

7 Labeled Peptides Manufacturing Cost Analysis

  • 7.1 Labeled Peptides Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Labeled Peptides
  • 7.4 Labeled Peptides Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Labeled Peptides Distributors List
  • 8.3 Labeled Peptides Customers

9 Labeled Peptides Market Dynamics

  • 9.1 Labeled Peptides Industry Trends
  • 9.2 Labeled Peptides Growth Drivers
  • 9.3 Labeled Peptides Market Challenges
  • 9.4 Labeled Peptides Market Restraints

10 Global Market Forecast

  • 10.1 Labeled Peptides Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Labeled Peptides by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Labeled Peptides by Type (2022-2027)
  • 10.2 Labeled Peptides Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Labeled Peptides by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Labeled Peptides by Application (2022-2027)
  • 10.3 Labeled Peptides Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Labeled Peptides by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Labeled Peptides by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    (Arg)9, FAM-labeled
    (Arg)9, TAMRA-labeled
    Others

    Segment by Application
    Protein Chemistry
    Immunology
    Histochemistry
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Pepscan
    JPT Peptide Technologies
    PEPTIDE INSTITUTE
    Merck
    BIOSYNTAN GmbH
    LifeTein
    Eurogentec

    Buy now